Tag Archive for: MDMA

Special Issue of Pharmacopsychiatry on Psychedelics in Psychiatry 2021 – the characteristics of disruptive treatments

Special Issue of Pharmacopsychiatry on Psychedelics in Psychiatry 2021 – Gerhard Gründer and Henrik Jungaberle on the difference of disruptive treatments


Henrik Jungaberle

Cover Pharmacopsychiatry Psychedelics 2021.jpg


A special issue of Pharmacopsychiatry

„Psychedelics in Psychiatry 2021“

The July 2021 special issue of Psychopharmacology is dedicated to the renaissance of psychedelics in psychiatry that has occurred during the past couple of years. “Psychedelics in Psychiatry 2021” contains four interesting review articles on different aspects of its historic development and current research as treatment in mood disorders and its effects in psychotherapy.
Together with Gerhard Gründer Henrik Jungaberle has co-authored a paper on “The potential role of psychedelic drugs in mental health care of the future”.

Prof. Dr. Gerhard Gründer describes the scope of the special issue in his editoral:

“It is important to be aware of the historical roots of our current medical practices. This is particularly true of the use of psychedelics for medical purposes. Nichols and Walter in their thoughtful review provide an overview of the historical basis on which all current psychedelic treatment research is based [5]. Treatment with a psychedelic is not just the application of a pill. Rather, it must always be embedded in psychotherapeutic support. The scope and nature of this psychotherapeutic program are the subjects of intense research, the current status of which is presented in the overview by Nayak and Johnson [6]. What is the mechanism of action of psychedelics? The entire spectrum of psychological and biological processes that are triggered by psychedelics is the subject of the review by Mertens and Preller [7]. They discuss the current state of research using the example of 2 possible future therapeutic indications, affective and substance use disorders. Finally, psychedelic therapy not only requires a new infrastructure in which it is carried out but also must be integrated into the existing system and differentiated from the recreational use of these substances. Many social, political, and cultural questions are affected by this enculturation. The challenges of how psychedelics could be implemented in a future mental health care system are discussed by Gründer and Jungaberle [8].”

TV: Andrea Jungaberle urges caution in “Radical Ideals: Drugs? Legalize!” on SWR3/ARD Mediathek

This is how Gülseren Ölcüm phrases the content of her episode in the ARD Mediathek: “Drugs as a cure for the soul? Gülseren Ölcüm meets activists who use psychedelics to expand their consciousness. And doctors who want to use them to treat the mentally ill. They are fighting for easier access. Some of them go further than the law allows.”

Conference: INSIGHT 2021 – an invitation to Berlin. Psychedelic research, therapy and drug development in Berlin

At INSIGHT 2021, scientists and therapists, pharmaceutical industry and anthropology, philosophers, and chemists will come together to determine the potential place of LSD, psilocybin, DMT, MDMA, and other psychedelic substances in the treatment of mental disorders. In addition, we will discuss the use of non-pharmacological methods to alter and cultivate states of consciousness and all that it takes to build such unusual states of consciousness a legitimate and safe place in society.

Podcast: Henrik in conversation with Darek Dwanda on values and programs of the MIND Foundation

Berlin’s MIND Foundation is one of Europe’s largest psychedelic therapy organizations with global aspirations. MIND has a range of amazing programs for therapists, academics, and anyone else interested in new psychedelic therapies. In this episode we discuss a range of issues including European psychedelic landscape, ethics of Psychedelic-Assisted Therapies, cultural issues, issues of growth, and many other issues related to healing with psychedelics.

Gert Scobel discusses drugs as medicine on 3SAT – with Franz Vollenweider, Thomas Metzinger und Magaly Tornay

Gert Scobel discusses new therapies with hallucinogenic drugs with historian Magaly Tornay, psychiatrist Franz Vollenweider, and philosopher and neuroethicist Thomas Metzinger.

Essay: Henrik Jungaberle and Rolf Verres on Rituals of Intoxication in Heidelberg University’s Ruperto Carola

To mark the launch of the research project “Ritual Dynamics and Salutogenesis in the Use and Misuse of Psychoactive Substances”, Henrik Jungaberle and Rolf Verres have written an essay on “Rituals of Intoxication”. In a brief cultural history, the tension between culture and medicine becomes visible. The topic was researched from 2002-20213 in a Collaborative Research Area of the German Research Foundation at Heidelberg University Hospital.